T.P. Sloan
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 6
- Ophthalmology top 5%
- Clinical Biochemistry top 10%
- Metabolism and Genetic Disorders 2
-
- Cancer Treatment and Pharmacology 2
-
- Receptor Mechanisms and Signaling 2
- Cancer therapeutics and mechanisms 1
-
- Mast cells and histamine 1
-
- Hormonal and reproductive studies 1
-
- Carcinogens and Genotoxicity Assessment 1
- Co-authors
- Jeffrey R. IdleA. MahgoubRichard L. SmithDavid A. EvansEnitan A. BababunmiRichard LancasterN. M. WoolhouseRobert L. Smith
- Journals
- Journal of Pharmacy and Pharmacology (1 paper)Cancer Letters (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United KingdomNigeriaGhana
In The Last Decade
T.P. Sloan
12 papers receiving 717 citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Pharmacology 483
- Ophthalmology 90
- Clinical Biochemistry 61
- Oncology 223
- Biological Psychiatry 14
Countries citing papers authored by T.P. Sloan
This map shows the geographic impact of T.P. Sloan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.P. Sloan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.P. Sloan more than expected).
Fields of papers citing papers by T.P. Sloan
This network shows the impact of papers produced by T.P. Sloan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.P. Sloan. The network helps show where T.P. Sloan may publish in the future.
Co-authorship network
The 15 scholars most cited alongside T.P. Sloan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 3 | |
| 2 | 1981 | 64 | |
| 3 | 1980 | 12 | |
| 4 | 1980 | 55 | |
| 5 | A family andpopulation study ofthegenetic polymorphism ofdebrisoquine oxidation ina white British population | 1980 | 2 |
| 6 | A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.breakdown → | 1980 | 448 |
| 7 | Application of the phenotyped panel approach to the detection of polymorphism of drug oxidation in man [proceedings]. | 1979 | 18 |
| 8 | 1979 | 73 | |
| 9 | 1979 | 10 | |
| 10 | Polymorphic hydroxylation of debrisoquine in Ghanaians [proceedings]. | 1979 | 2 |
| 11 | 1978 | 92 | |
| 12 | 1978 | 1 |
About T.P. Sloan
T.P. Sloan is a scholar working on Pharmacology, Clinical Biochemistry and Pharmaceutical Science, having authored 12 papers that have together received 780 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Metabolism and Genetic Disorders (2 papers), Receptor Mechanisms and Signaling (2 papers), Cancer Treatment and Pharmacology (2 papers), Cancer therapeutics and mechanisms (1 paper), Mast cells and histamine (1 paper), Hormonal and reproductive studies (1 paper) and Carcinogens and Genotoxicity Assessment (1 paper). The work is most often cited by research in Pharmacology (483 citations), Ophthalmology (90 citations) and Clinical Biochemistry (61 citations). T.P. Sloan has collaborated with scholars based in United Kingdom, Nigeria and Ghana. Frequent co-authors include Jeffrey R. Idle, A. Mahgoub, Richard L. Smith, David A. Evans, Enitan A. Bababunmi, Richard Lancaster, N. M. Woolhouse, Robert L. Smith, Philip A. Wood and RL Smith. Their work appears in journals such as Journal of Pharmacy and Pharmacology, Cancer Letters, Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.